A genetic variant may help keep an individual’s “good” cholesterol in check.

Heart disease is still the leading cause of death for men in Tennessee and cancer deaths continue to move further away from the Centers for Disease Control and Prevention’s Healthy People 2020 goal, according to the 2012 Tennessee Men’s Health Report Card.

A new screening tool – using glowing fish embryos – could identify therapeutics for myocardial hypertrophy and heart failure.

Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol.

Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis.

A new implantable device currently being studied gives heart failure patients the ability to monitor their heart and take action when their condition begins to worsen.